Abstract

Led by Dr. Dennis Liotta, the Liotta Research Group (LRG) stands as a dynamic medicinal chemistry organization within Emory University. This presentation commences with an overview of Dr. Liotta's remarkable achievements in the field of antiviral research. The initial segment will delve into the success stories of three groundbreaking drugs developed by Emory and its spinoffs, addressing critical public health emergencies such as the HIV/AIDS epidemic, the HCV challenge, and the COVID-19 pandemic. Subsequently, the discussion will shift focus to illuminate the LRG's recent strides in drug discovery across diverse therapeutic domains, with particular emphasis on advancements in oncology and neurological diseases. Throughout the presentation, Dr. Liotta will provide insights into the nuances of drug discovery and development within an academic setting. He will offer a unique perspective shaped by his extensive experience in reshaping the landscape of academic drug discovery at Emory.

Date: 2 Aug 2024 (Friday)
Time: 11:00 a.m.
Venue: LTG (HKUST)